It has been suggested that hepatobiliary carcinomas are less frequent in Wilson’s disease (WD) than in liver diseases of other etiology. However, the protective role of copper against malignancies is debated. Only a few cases of cholangiocarcinoma (CCC) in WD have been published. Here we report on a case of a 47-year-old male H1069Q homozygous, Kayser-Fleischer ring positive WD patient with a low ceruloplasmin level who was followed up and treated with chelating agents throughout nine years. The patient presented with neurological symptoms and liver cirrhosis at diagnosis. Clinical symptoms regressed after the treatment initiation. Rapidly developed tumour metastases were found in the bones, lung and liver (without jaundice). Autopsy revealed cholangiocarcinoma as the primary tumour confirmed by strong CK7 positivity and glypican-3 negativity. The curiosity of the presented case is the very rapid development of CCC despite continuous chelating agent therapy.
CITATION STYLE
Németh, D., Folhoffer, A., Smuk, G., Kajtár, B., Tornóczky, T., & Szalay, F. (2017). Cholangiocarcinoma in wilson’s disease – A case report. Journal of Gastrointestinal and Liver Diseases, 26(3), 305–308. https://doi.org/10.15403/jgld.2014.1121.263.nem
Mendeley helps you to discover research relevant for your work.